Abstract
The COVID-19 pandemic has considerably disrupted health care delivery, presenting challenges for dermatologists. We investigated the scope of delayed treatment for melanoma and non-melanoma skin cancers in relation to other cancer types during the COVID-19 pandemic. Respondent data from the National Health Interview Survey (NHIS) was analyzed for the year 2020. Data included demographic information as well as delays and cancellations of cancer treatments due to the coronavirus pandemic. Multivariate odds ratios were calculated using the statistical software, IBM SPSS.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
